Detalhe da pesquisa
1.
Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Gynecol Oncol
; 138(1): 109-14, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25933682
2.
Immunohistochemical findings and clinicopathological features of breast cancers with pathogenic germline mutations in Non-BRCA genes.
Hum Pathol
; 146: 49-56, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38608781
3.
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease.
Cancer Cell
; 3(5): 459-69, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12781364
4.
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features.
Breast Cancer Res
; 12(1): R12, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20149218
5.
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers.
Breast Cancer Res
; 12(6): R95, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21080930
6.
Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program.
Gynecol Oncol
; 116(3): 295-300, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20042225
7.
Clinical characteristics and choices regarding risk-reducing surgery in BRCA mutation carriers.
Gynecol Obstet Invest
; 69(4): 270-3, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20090358
8.
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial).
J Clin Oncol
; 38(14): 1539-1548, 2020 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32097092
9.
Management of hematological malignancies during pregnancy.
Am J Hematol
; 84(12): 830-41, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19844988
10.
Choosing high-risk screening vs. surgery and the effect of treatment modality on anxiety and breast-specific sensuality in BRCA mutation carriers.
Gland Surg
; 8(3): 249-257, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31328104
11.
Is tumor board relevant?
Breast J
; 19(3): 351-3, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23577689
12.
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.
N Engl J Med
; 348(13): 1201-14, 2003 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-12660384
13.
Genetics: predisposition and management.
Clin Obstet Gynecol
; 54(1): 180-90, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21278518
14.
Advances in Medical Management of Early Stage and Advanced Breast Cancer: 2015.
Semin Radiat Oncol
; 26(1): 59-70, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26617211
15.
Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial.
Clin Cancer Res
; 21(10): 2305-14, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25688159
16.
Risk factors for breast cancer.
Obstet Gynecol Clin North Am
; 29(1): 159-72, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11892864
17.
Adjuvant therapy in breast cancer.
Obstet Gynecol Clin North Am
; 29(1): 201-8, ix, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11892867
18.
The identification and management of hereditary breast and ovarian cancer.
Med Health R I
; 86(2): 48-51, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12666278
19.
Frequent pathologic complete responses in aggressive stages II to III breast cancers with every-4-week carboplatin and weekly paclitaxel with or without trastuzumab: a Brown University Oncology Group Study.
J Clin Oncol
; 27(28): 4693-700, 2009 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19720916
20.
For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
Am J Clin Oncol
; 31(1): 39-42, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18376226